Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
Arthritis Rheum., Sep;63(9):2755-63 (2011)
Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance.
Autoimmun Rev., Jul;11(9):611-4 (2012)
Tolerance induced by anti-DNA Ig peptide in (NZBÃ?NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells.
Clin. Immunol., Mar;142(3):291-5 (2012)
Genes, tolerance and systemic autoimmunity.
Autoimmun Rev., Jul;11(9):664-9 (2012)
Accelerated atherosclerosis in patients with SLE--mechanisms and management.
Nat Rev Rheumatol., Apr;8(4):214-23 (2012)
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Arthritis Care Res (Hoboken)., Jun;64(6):797-808 (2012)
Targeted therapies in systemic lupus erythematosus: successes, failures and future.
Ann. Rheum. Dis., Mar;70 Suppl 1:i64-i66 (2011)
Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin.
Lupus., Jul;19(8):913-7 (2010)
CD8+ Tregs in lupus, autoimmunity, and beyond.
Autoimmun Rev., Jun;9(8):560-8 (2010)
PD-1, gender, and autoimmunity.
Autoimmun Rev., Jun;9(8):583-7 (2010)
Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRÎ², chemotaxis and TNFÎ± production.
Clin. Immunol., Oct;137(1):147-56 (2010)
Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
J. Immunol., Dec;185(11):6563-71 (2010)
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus.
Arthritis Care Res (Hoboken)., Feb;62(2):258-65 (2010)
Leptin in non-autoimmune inflammation.
Inflamm Allergy Drug Targets., Sep;8(4):285-91 (2009)
Distinct gene signature revealed in white blood cells, CD4(+) and CD8(+) T cells in (NZBx NZW) F1 lupus mice after tolerization with anti-DNA Ig peptide.
Genes Immun., Jun;11(4):294-309 (2010)
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.
Arthritis Rheum., Aug;60(8):2428-37 (2009)
Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.
J. Immunol., Jun;182(12):7415-21 (2009)
Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.
J. Immunol., Aug;183(3):1518-22 (2009)
Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus.
Expert Opin Biol Ther., Feb;9(2):201-6 (2009)
Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin.
J. Immunol., Feb;182(3):1674-80 (2009)